Carmustine Kit
Product Images NDC 68475-503
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Carmustine (NDC 68475-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
8298f1a6 047b 4744 976b 3bbec06c22ca 02
The "Product Kit Guard" is a safety device for "Carmustine for Injection, USP, 100 mg/vial". It is recommended not to remove the vials from the guard, and to keep it in a carton until the time of use. The instructions recommend wearing gloves when handling the Product Kit Guard, and discarding it after use. To use the Product Kit Guard, one needs gloves, alcohol swabs, and a sterile syringe. The "Product Kit Guard" has two compartments, one for the "100mg Carmustine vial," and the other for the "3mL sterile diluent vial." The product information leaflet should be read before administration. To get more information, Navinta LLC can be contacted at +1-609-883-1135.*
8298f1a6 047b 4744 976b 3bbec06c22ca 03
8298f1a6 047b 4744 976b 3bbec06c22ca 04
This is a description for Carmustine for Injection, USP. It is to be used for intravenous infusion after reconstitution and should be refridgerated immediately after purchase. The reconstituted vials should be examined for crystal formations before use, and if observed, warm the vial to room temperature and agitate to redisolve the crystals. The package includes the usual dosage, directions for use, and precautions. This product is manufactured by Navinta LLC and is not available for return once purchased.*
8298f1a6 047b 4744 976b 3bbec06c22ca 05
This is a description of Carmustine for Injection, a medicine packaged in a carton containing one vial of Carmustine for Injection and one vial of Sterile Diluent for Carmustine for Injection. Carmustine for Injection must be mixed with the provided sterile diluent, and the resulting solution contains 3.3 mg of the medicine per each milliliter in 10% ethanol. The solution is to be refrigerated immediately, and any unused portion must be discarded. Each carton contains 1 vial of Carmustine for Injection 100 mg, and is available for intravenous infusion after reconstitution. The usual dosage and safety precautions should be reviewed before use. The manufacturer is Navinta LLC.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.